| 000 | 00934nab a2200265 a 4500 | ||
|---|---|---|---|
| 001 | 006845 | ||
| 008 | 150305r2008 ck r 000 u spa d | ||
| 012 | _aQuincenal | ||
| 014 | _aRevista | ||
| 100 | 1 | _aDaniels, David. | |
| 210 | _aGen | ||
| 222 | _aGenetic Engineering y Biotechnology New / Mary Ann Liebert | ||
| 245 |
_aRefining Protein Drug Formulation: _bStrategies for Overcoming Critical. / _cDavid Daniels. |
||
| 260 |
_a[Estados Unidos]: _bMary Ann Liebert, _c2008. |
||
| 300 | _a74 p. ; 35 cm. | ||
| 362 |
_aVol. 28 _bNo. 16 _c(Sep. 15, 2008) _dp. 1 - 50 |
||
| 650 | _aINVESTIGACION GENETICA | ||
| 773 | 0 |
_aGenetic Engineering y Biotechnology New / Mary Ann Liebert _gVol. 28,No. 16,(Sep. 15, 2008),p. 1 - 50 |
|
| 592 |
_aBiblioteca Central _bR3109 - Donación _cHemeroteca |
||
| 593 | _a26 de septiembre de 2008 | ||
| 594 | _aImágenes | ||
| 595 | _aIngeniería genética | ||
| 942 |
_2ddc _cAS |
||
| 999 |
_c22809 _d22809 |
||